Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • Corrigendum: Targeting the PI3...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

Corrigendum: Targeting the PI3K/AKT/mTOR pathway in lung cancer: mechanisms and therapeutic targeting

Bibliographic Details
Published in:Frontiers in Pharmacology
Main Authors: Min Qiang, Zhe Chen, Hongyang Liu, Junxue Dong, Kejian Gong, Xinjun Zhang, Peng Huo, Jingjun Zhu, Yifeng Shao, Jinazun Ma, Bowei Zhang, Wei Liu, Mingbo Tang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Subjects:
PI3K/Akt/mTOR pathway
lung cancer
PI3K inhibitors
Akt inhibitors
mTOR inhibitors
natural products
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1591443/full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2025.1591443/full

Similar Items

  • Targeting the PI3K/AKT/mTOR pathway in lung cancer: mechanisms and therapeutic targeting
    by: Min Qiang, et al.
    Published: (2025-02-01)
  • PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
    by: Antonino Glaviano, et al.
    Published: (2023-08-01)
  • Recent Advances in Dual PI3K/mTOR Inhibitors for Tumour Treatment
    by: Xianbo Wu, et al.
    Published: (2022-05-01)
  • Autophagy as a Vital Therapy Target for Renal Cell Carcinoma
    by: Ying-hua He, et al.
    Published: (2021-02-01)
  • The Emerging Role and Clinical Significance of PI3K-Akt-mTOR in Rhabdomyosarcoma
    by: Ilaria Versari, et al.
    Published: (2025-02-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs